Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
FBTIX vs XBI
Shared holdings
40
FBTIX covered by XBI
28.44%
XBI covered by FBTIX
28.44%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
FBTIX (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| ABBVIE INC | 16.04% | |
| GILEAD SCIENCES INC | 6.35% | |
| ALNYLAM PHARMACEUTICALS INC | 4.85% | |
| Ascendis Pharma A/S | 4.34% | |
| COGENT BIOSCIENCES INC | 3.70% | |
| ARGENX SE SPONSORED ADR | 3.52% | |
| Fidelity Securities Lending Cash Central Fund | 3.47% | |
| INSMED INC | 3.35% | |
| VIRIDIAN THERAPEUTICS INC | 3.05% | |
| BIOGEN INC | 2.74% | |
| AMGEN INC | 2.67% | |
| VAXCYTE INC | 2.21% | |
| STRUCTURE THERAPEUTICS INC ADR | 2.20% | |
| NUVALENT INC-A | 2.20% | |
| DIANTHUS THERAPEUTICS INC | 2.02% | |
| AMYLYX PHARMACEUTICALS INC | 1.80% | |
| MODERNA INC | 1.54% | |
| APOGEE THERAPEUTICS INC | 1.54% | |
| XENON PHARMACEUTICALS INC | 1.51% | |
| CRINETICS PHARMACEUTICALS INC | 1.41% | |
| PRAXIS PRECISION MEDICINES INC | 1.40% | |
| SCHOLAR ROCK HOLDING CORP | 1.34% | |
| ORUKA THERAPEUTICS INC | 1.26% | |
| SPYRE THERAPEUTICS INC | 1.24% | |
| UCB SA | 1.19% | |
| UNIQURE N.V. | 1.17% | |
| UPSTREAM BIO INC | 1.11% | |
| ROIVANT SCIENCES LTD | 1.09% | |
| NATERA INC | 1.07% | |
| OLEMA PHARMACEUTICALS INC | 1.04% | |
| VIKING THERAPEUTICS INC | 0.97% | |
| NEWAMSTERDAM PHARMA COMPANY NV | 0.94% | |
| CYTOKINETICS INC | 0.93% | |
| KYMERA THERAPEUTICS INC | 0.87% | |
| JADE BIOSCIENCES INC | 0.72% | |
| CG ONCOLOGY INC | 0.67% | |
| RHYTHM PHARMACEUTICALS INC | 0.67% | |
| ENLIVEN THERAPEUTICS INC | 0.65% | |
| ZENAS BIOPHARMA INC | 0.60% | |
| DISC MEDICINE INC | 0.57% | |
| ARCELLX INC | 0.51% | |
| STOKE THERAPEUTICS INC | 0.50% | |
| SONOMA BIOTHERAPEUTICS INC SER B PFD PP | 0.49% | |
| TRAVERE THERAPEUTICS INC | 0.48% | |
| MINERALYS THERAPEUTICS INC | 0.43% | |
| CYTOMX THERAPEUTICS INC | 0.40% | |
| ANAPTYSBIO INC | 0.36% | |
| SOLENO THERAPEUTICS INC | 0.36% | |
| CELLDEX THERAPEUTICS INC | 0.35% | |
| REZOLUTE INC | 0.34% |
XBI (March 31, 2026)
| Security | Weight | |
|---|---|---|
| State Street Navigator Securities Lending Portfolio II | 7.47% | |
| APELLIS PHARMACEUTICALS INC | 1.70% | |
| ALKERMES PLC | 1.34% | |
| MADRIGAL PHARMACEUTICALS INC | 1.28% | |
| TG THERAPEUTICS INC | 1.25% | |
| INSMED INC | 1.24% | |
| SCHOLAR ROCK HOLDING CORP | 1.20% | |
| APOGEE THERAPEUTICS INC | 1.19% | |
| PROTAGONIST THERAPEUTICS INC | 1.15% | |
| SUMMIT THERAPEUTICS INC | 1.15% | |
| UNITED THERAPEUTICS CORP DEL | 1.15% | |
| PRAXIS PRECISION MEDICINES INC | 1.14% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.14% | |
| COGENT BIOSCIENCES INC | 1.13% | |
| BRIDGEBIO PHARMA INC | 1.10% | |
| PTC THERAPEUTICS INC | 1.09% | |
| CYTOKINETICS INC | 1.09% | |
| ALNYLAM PHARMACEUTICALS INC | 1.09% | |
| EXELIXIS INC | 1.08% | |
| NUVALENT INC-A | 1.08% | |
| KYMERA THERAPEUTICS INC | 1.08% | |
| CG ONCOLOGY INC | 1.08% | |
| NATERA INC | 1.07% | |
| NEUROCRINE BIOSCIENCES INC | 1.07% | |
| TWIST BIOSCIENCE CORP | 1.07% | |
| KRYSTAL BIOTECH INC | 1.07% | |
| VAXCYTE INC | 1.07% | |
| MIRUM PHARMACEUTICALS INC | 1.06% | |
| AMICUS THERAPEUTICS INC | 1.06% | |
| IONIS PHARMACEUTICALS INC | 1.06% | |
| TRAVERE THERAPEUTICS INC | 1.06% | |
| ARCELLX INC | 1.06% | |
| REGENERON PHARMACEUTICALS INC | 1.05% | |
| INCYTE CORP | 1.05% | |
| CELCUITY INC | 1.04% | |
| REVOLUTION MEDICINES INC | 1.03% | |
| HALOZYME THERAPEUTICS INC | 1.03% | |
| RHYTHM PHARMACEUTICALS INC | 1.02% | |
| BIOGEN INC | 1.02% | |
| ARCUTIS BIOTHERAPEUTICS INC | 1.01% | |
| ABBVIE INC | 1.01% | |
| GILEAD SCIENCES INC | 1.01% | |
| CRISPR THERAPEUTICS AG | 1.01% | |
| BIOMARIN PHARMACEUTICAL INC | 0.99% | |
| ROIVANT SCIENCES LTD | 0.99% | |
| AMGEN INC | 0.98% | |
| IMMUNITYBIO INC | 0.98% | |
| BEAM THERAPEUTICS INC | 0.96% | |
| VIKING THERAPEUTICS INC | 0.96% | |
| VERA THERAPEUTICS INC | 0.96% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.